• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of influenza vaccine-induced cell-mediated immunity: Comparison between methods using peripheral blood mononuclear cells and whole blood

tetano

Editor, Senior Moderator
Microbiol Immunol. 2019 May 9. doi: 10.1111/1348-0421.12687. [Epub ahead of print]
[h=1]Evaluation of influenza vaccine-induced cell-mediated immunity: Comparison between methods using peripheral blood mononuclear cells and whole blood.[/h] Otani N[SUP]1[/SUP], Shima M[SUP]1[/SUP], Ueda T[SUP]2[/SUP], Ichiki K[SUP]2[/SUP], Nakajima K[SUP]2[/SUP], Takesue Y[SUP]2[/SUP], Okuno T[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Assessments of cell-mediated immunity (CMI) might be critical to evaluate the ability of an individual to protect himself/herself against influenza virus infection. However, CMI has been difficult to evaluate because no simple CMI measurement method is available. We aimed to compare the performance of a CMI measurement method that we developed, which involves reacting whole blood with antigen, with the conventional method based on isolating peripheral blood mononuclear cells (PBMCs). We compared and tested correlations between these methods before and after vaccination in 26 healthy adults (28-58 years old; 12 men and 14 women). Changes in CMI after influenza vaccination in PBMCs cultured with antigen for 48 and 96 h and whole blood cultured with antigen for 48 h were studied. We found CMI measurement results using whole blood on day 2 and PBMCs on day 4 to be correlated. Spearman's correlation coefficients with four antigens [A (H1N1), A (H3N2), B (Yamagata lineage), and B (Victoria lineage)] before vaccination were 0.55, 0.61, 0.58, and 0.70, respectively, and were 0.40, 0.45, 0.62, and 0.52 after vaccination. CMI was detected sooner when whole blood was reacted with antigen than when PBMCs were reacted with antigen. The positive reaction rate of influenza A (H1N1 and H3N2) in whole blood on day 2 was higher than that in PBMCs on day 2. Our method is simple and may be useful for vaccine development as it can measure CMI with a small amount of blood without separation into PBMCs. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] cell-mediated immunity; influenza; peripheral blood mononuclear cell; vaccine; whole blood

PMID: 31070266 DOI: 10.1111/1348-0421.12687
 
Back
Top Bottom